2022
21
March
2022
|
09:27
Europe/Amsterdam
BIOTRONIK today announced the CE approval for HeartInsight®, its remote heart failure (HF) management solution that accurately identifies patients at higher risk of HF decompensation early on. HeartInsight predicts two out of three HF hospitalization...
Read more